Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06268288 · ClinicalTrials.gov registry record · NA

Non-invasive Vagal Neurostimulation (nVNS) in Adolescents With Postural Orthostatic Tachycardia Syndrome (POTS)

A NA study of Postural Tachycardia Syndrome and Postural Orthostatic Tachycardia Syndrome, sponsored by Mayo Clinic.

Completed
Registry status
NA
Development phase
40
Enrollment target
2
Study locations

NCT06268288 is a NA study of Postural Tachycardia Syndrome and Postural Orthostatic Tachycardia Syndrome that has completed, run by Mayo Clinic. The registered enrollment target is 40 participants, below the 81-participant average among 19 other Postural Tachycardia Syndrome trials with a reported enrollment target (51% lower). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06268288, a NA study of Postural Tachycardia Syndrome and Postural Orthostatic Tachycardia Syndrome, has completed, sponsored by Mayo Clinic.

COMPLETED
Registry status
NA
Development phase
40 participants
Enrollment target
2
Study locations

Study Summary

The purpose of this study is to determine if nVNS will decrease autonomic symptom intensity (COMPASS-31 and Child Functional Disability Inventory) in adolescent patients with postural orthostatic tachycardia syndrome (POTS) in comparison to standard recovery STEPS management.

Interventions

  • DEVICE GammaCore intervention
  • OTHER STEPS management protocol

Study Locations (2)

Minnesota

  • Mayo Clinic - Rochester
  • Mayo Clinic in Rochester - Rochester

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2024-02-14
Est. Completion 2024-10-05
Phase NA

Sponsor

Mayo Clinic

2,844 total trials

What the Registry Record Tells You About NCT06268288

The ClinicalTrials.gov registry entry for NCT06268288 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 81-participant average among 19 other Postural Tachycardia Syndrome trials with a reported enrollment target (51% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Postural Tachycardia Syndrome appearing as the primary indexed condition, and to 2 interventions - of which GammaCore intervention is the first listed.

NCT06268288 reports 2 study locations spanning 1 distinct geographic area - top geographies include Minnesota.

Frequently Asked Questions

What is clinical trial NCT06268288 about?

NCT06268288 is a clinical study titled "Non-invasive Vagal Neurostimulation (nVNS) in Adolescents With Postural Orthostatic Tachycardia Syndrome (POTS)". The purpose of this study is to determine if nVNS will decrease autonomic symptom intensity (COMPASS-31 and Child Functional Disability Inventory) in adolescent patients with postural orthostatic tachycardia syndrome (POTS) in comparison to standard recovery STEPS management.

What is the current status of trial NCT06268288?

This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2024-02-14. Estimated completion is 2024-10-05.

What conditions does trial NCT06268288 study?

This clinical trial studies the following conditions: Postural Tachycardia Syndrome, Postural Orthostatic Tachycardia Syndrome, Autonomic Dysfunction, POTS - Postural Orthostatic Tachycardia Syndrome.

What interventions are being tested in trial NCT06268288?

The interventions under investigation include: GammaCore intervention (DEVICE), STEPS management protocol (OTHER).

Who is sponsoring clinical trial NCT06268288?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06268288 being conducted?

This trial has 2 study locations across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Postural Tachycardia Syndrome

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.